View the PHOMOBO registration information details.
Back to drug list
ItemsDrug Registration information
ID981
No981
Brand NamePHOMOBO
IngredientsMOBOCERTINIB 40 MG
Dosage FormCAPSULE
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 120 TABLETS/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF ADULT PATEINTS WITH LOCALLY ADVANCE OR METASTATIC NON SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR EXON 20 INSERTION MUTATION
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE CAPSULE CONTAINS WHITE GRANULE TO PALE YELLOW,
Note
License OwnerFACTORY NO.2
ManufacturerFACTORY No.2
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No05 L 0975/23
FDD Registration Date17/05/2023
Expiry Date16/05/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA